Ireland-based biopharmaceutical company Jazz Pharmaceuticals plans to raise $500m through a private placement of senior notes.
The company plans to use the proceeds towards general corporate purposes and business development.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Chinese pharmaceutical products provider Kangmei Pharmaceutical has completed a public offering of medium-term notes to raise CNY2bn ($299.58m).
Due 2022, the notes carry a coupon rate of 5.29%.